Published 3 years ago

India gov't seals deal for 300 mln Biological-E COVID-19 vaccine doses

Summary by Reuters

India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).

0 Articles

All

Left

Center

Right

Times of India

Covid-19: Govt seals deal for 300 million vaccine doses from Biological

The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement. These vaccine doses will be manufactured and stockpiled by Biological-E from August-December 2021.

3 years ago·India

Read Full Article

Yahoo News

India signs deal with domestic vaccine maker Biological-E for 300 million doses

BENGALURU (Reuters) -India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million), the first such order for unapproved shots. Biological E., which also has a separate deal to produce about 600 million doses of Johnson & Johnson's COVID-19 shot annually, said on Tuesday it entered into a licensing agreement with Providence Therapeut…

3 years ago·Los Angeles, United States

Read Full Article

News18 India

Biological-E Vaccines May be Out in 'Few Months' as Centre Finalises 'Advance' Deal for 30 Crore Doses

The Union Ministry of Health finalised advance arrangement for 30 crore Covid-19 vaccine doses with Hyderabad-based M/s Biological-E Ltd on Thursday.

3 years ago·India

Read Full Article

The Hindu

COVID-19 vaccine: Health Ministry finalises arrangements with Hyderabad firm for 30 crore doses

These vaccine doses would be manufactured and stockpiled by Biological-E from August-December 2021, the Ministry said in a statement.

3 years ago·India

Read Full Article

Reuters

India gov't seals deal for 300 mln Biological-E COVID-19 vaccine doses

India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).

3 years ago·United Kingdom

Read Full Article

NDTV

Centre Signs Deal To Get 2nd Made-In-India Vaccine, 30 Crore Doses Booked

Aiming at a huge vaccination target, the government has booked 30 crore doses of Hyderabad-based Biological-E's Covid vaccine, which is still in clinical trials. The Health Ministry will make an advance payment of Rs 1,500 crore to the company for wh

3 years ago·New Delhi, India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.